Author Correction: Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer

Affiliations

• ¹ Department of Cell Biology, Harvard Medical School, Boston, MA, USA. carman_li@hms.harvard.edu.
• ² Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
• ³ Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
• ⁴ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ⁵ Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ⁶ Department of Biology, University of Massachusetts Boston, Boston, MA, USA.
• ⁷ Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ⁸ Genentech, South San Francisco, CA, USA.
• ⁹ Cancer Research Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
• ¹⁰ Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ¹¹ Department of Cell Biology, Harvard Medical School, Boston, MA, USA. joan_brugge@hms.harvard.edu.
• ¹² Broad Institute of MIT and Harvard, Cambridge, MA, USA. joan_brugge@hms.harvard.edu.